Support The Moscow Times!

Novo Nordisk Challenges

Insulin manufacturer Novo Nordisk will challenge a claim by the Federal Anti-Monopoly Service that it violated competition rules, Katrine Sperling, a spokeswoman for the Denmark-based company, said Monday.

“We have decided to challenge their decision in Moscow’s Court of Arbitration,” Sperling said.

If Novo Nordisk loses, the company could be fined as much as 15 percent of its Russian sales, the anti-monopoly agency said Friday. 


Read more

We need your help now more than ever.

Independent media outlets and journalists in Russia are being increasingly targeted with “foreign agent” and “undesirable” labels, threatening the existence of the free press day by day.

Your donation to The Moscow Times directly supports the last independent English-language news source within Russia.